QT
APRE icon

Quantamental Technologies’s Aprea Therapeutics APRE Stock Holding History

Quantamental Technologies’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-568
Closed -$9K – 495
2022
Q2 		$9K Sell
568
-70
-11% -$1.61K ﹤0.01% 400
2022
Q1 		$24K Sell
638
-50
-7% -$2.05K 0.01% 352
2021
Q4 		$39K Hold
688
– – 0.02% 371
2021
Q3 		$70K Hold
688
– – 0.05% 276
2021
Q2 		$67K Buy
+688
New +$63.6K 0.06% 233

Other funds holding APRE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quantamental Technologies's APRE Position: Q3 2022 in Review

Quantamental Technologies sold out of Aprea Therapeutics (APRE) in Q3 2022, closing a stake of 568 shares — an estimated $9K sold.

Quantamental Technologies first reported a position in APRE in Q2 2021 and held it in 5 quarters. The position peaked at $70K in Q3 2021. 26 funds tracked by Wall St. Rank hold APRE as of Q3 2022.

  • Quantamental Technologies reported no remaining Aprea Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Quantamental Technologies sold 568 Aprea Therapeutics shares in Q3 2022, an estimated $9K.
  • Quantamental Technologies first reported a position in Aprea Therapeutics in Q2 2021 and held it in 5 quarters.
  • Quantamental Technologies's Aprea Therapeutics position peaked at $70K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q3 2022.

Based on Quantamental Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.